Xeltis AG

https://www.xeltis.com

Xeltis is a European medical device company based in Zurich, Switzerland and in Eindhoven, The Netherlands. Xeltis successfully completed an oversubscribed series B financing round of €27 million in 2014, extended to €30 million in 2015. Investors include Life Sciences Partners, The Netherlands (LSP), Kurma Partners, France (Kurma), VI Partners, Switzerland (VI) and private shareholders. *

	Start	2006-01-01 splitoff
	Group	Xeltis (Group)
	Industry	medical device
	Industry 2	Endogenous Tissue Growth product (ETG)
	Person	Grandidier, Laurent (Xeltis 201412 CEO)
	Person 2	Lehn, Jean-Marie (Therascope founder)

	Region	Zürich ZH
	Country	Switzerland
	Street	35 Seefeldstr.
	City	8008 Zürich ZH
	Tel	+41-44-269-7979
		Address record changed: 2024-01-05

Basic data	Employees	n. a.

		* Document for »About Section«:

		Record changed: 2020-05-09

Picture Kenes Exhibitions Biomed Israel 2024 Tel Aviv 650x200px

More documents for Xeltis (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)